Microkeratome creates flaps for LASIK, LASEK procedures
January 1st 2004Barranquilla, Colombia-The Carriazo-Pendular microkeratome (Schwind Eye-Tech Solutions) is a highly versatile microkeratome that can be used with great safety to produce high-quality flaps for LASIK and perhaps even for LASEK procedures, said Cesar Carriazo, MD.
Epikeratome brings Epi-LASIK into hands of refractive surgeons
January 1st 2004The Centurion SES EpiEdge epikeratome (CIBA Vision) is a simple instru-ment to use that safely and reliably separates the epithelium from the stroma via mechanical forces to create an intact epithelial sheet in eyes undergoing Epi-LASIK, said Ioannis G. Pallikaris, MD, PhD, who invented Epi-LASIK and participated in the development of the epikeratome.
Supersonic waterjet able to cut LASIK flap with precision
January 1st 2004The HydroKeratome Waterjet System (Visijet Inc.), the first microkeratome that creates a LASIK flap using a continuous beam of ultra-high-pressure water instead of a metal blade, debuted at the 2003 annual meeting of the American Academy of Ophthalmology in Anaheim.
Alcon rings NYSE bell; anecortave trials begin
January 1st 2004New York-Tim Sear, Alcon Inc.'s chairman, president, and chief executive officer, rang the closing bell of the New York Stock Exchange at 4 p.m. Dec. 4 to celebrate the company's dramatic rise in stock price since its initial public offering.
FDA OKs duo of surgical devices from Nidek
January 1st 2004Fremont, CA-Nidek is introducing a new combination pachymeter and A-scan ultrasound unit, and what it is calling the industry's smallest green laser photocoagulator to the United States market. The products, which were launched at the American Academy of Ophthalmology annual meeting, both recently received FDA approval for commercial sales and marketing.
AMO, Alcon in dispute over phaco patents
January 1st 2004Santa Ana, CA-Advanced Medical Optics (AMO) is claiming, in a complaint filed in federal court, that Alcon's Infiniti and Series 20000 Legacy phacoemulsification systems infringe AMO patents for advanced fluidics technologies in the removal of cataracts.
ACES, SEE delegates merge for 'quality surgery' discussion
January 1st 2004Marco Island, FL-The American College of Eye Surgeons (ACES) andthe Society for Excellence in Eyecare (SEE), along with Ophthalmology Times,will join for the first time to present the SEE Island/Quality Surgery XVIIISeminar. The conference, to be held Feb. 28 to March 3 at the recently renovatedMarco Island Marriott Resort, will merge the best faculty and presentationsfrom the two ophthalmic societies.
Resource-based relative value scale dictates revenue stream
December 15th 2003Physicians need to have a firm understanding of the resource-based relative value scale (RBRVS) because this scale assigns valuation for billions of dollars worth of procedures and services that physicians provide annually. In addition, it directly has an impact on how the money will be apportioned.
Restoration of accommodation possible after cataract surgery
December 15th 2003Antwerp, Belgium-Patients who have received the CrystaLens AT-45 accommodating IOL (eyeonics, formerly C&C Vision, Aliso Viejo, CA) after cataract extraction achieve very good distance and intermediate vision as well as improvements in their near vision, according to Erik L. Mertens, MD, FEBO, director and ophthalmic surgeon at Antwerp Eye Center, Antwerp, Belgium.
New laser shows good results for myopia, astigmatism
December 15th 2003The Allegretto excimer laser (WaveLight Laser Technologie, Erlangen, Germany) improves refractive predictability and enhances the outcome of LASIK, based on the results of a recently completed trial of the laser system in patients with myopia and myopic astigmatism, said Karl G. Stonecipher, MD.
LASIK outcomes better with preoperative aberrometry data
December 15th 2003Atlanta-LASIK based on preoperative aberrometry data reduces the amount of postoperative halo and creates a sharper retinal image compared with conventional LASIK treatment, according to results of a retrospective study conducted at Emory Vision in Atlanta.
Results promising for wavefront-guided hyperopic LASIK
December 15th 2003Ottawa-Results from the first cohort of hyperopic patients treated with wavefront-guided LASIK using the CustomVue System (VISX) show excellent safety, predictability, and stability with unparalleled vision outcomes, reported W. Bruce Jackson, MD.
Wavefront technology still making big news in 2003
December 15th 2003Developments in refractive surgery are interdependent and encompass diagnostics, surgical technology, and supportive therapeutics, all of which have a common goal: emmetropia. A number of advances have grabbed the attention of refractive surgeons over the past year, such as improvements in lasers, materials, and refinements in indications for certain refractive procedures. Wavefront technology is still taking center stage.
Phaco improved with burst mode setting
December 15th 2003Portland, OR-The addition of the burst mode to the Millennium Phacoemulsification System (Bausch & Lomb, Rochester, NY) is a boon to the system, according to a recent study. Using the burst mode during cataract surgery reduces the amount of energy that enters the eye, which allows for a less invasive procedure and improved visual outcomes.
Aspheric IOL enhances mesopic contrast sensitivity
December 15th 2003Munich, Germany-The aspheric Z9000 IOL (Tecnis, Pfizer) is associated with better mesopic contrast sensitivity relative to conventional IOLs, but does not maintain its superiority to spherical implants when testing is performed under mesopic conditions with glare, said Mike P. Holzer, MD, at the European Society of Cataract and Refractive Surgeons annual meeting.
Rock-hard cataracts pose various challenges for surgeon
December 15th 2003Although advanced nuclear sclerotic cataracts are seen with less frequency within the average U.S. practice, the rock-hard cataract does occasionally present in our examining lane and on the operating table. These dense lenses can be some of our most difficult cases due to numerous intrinsic challenges including poor visibility, fibrotic or fragile anterior capsules, large lens size, adherent cortical capsular connections, a thin or deficient epinucleus, and tenacious leathery lens fibers. Special considerations should allow the surgeon to approach these advanced cataracts with more confidence and decrease the incidence of serious intraoperative complications.
Ultra-low-energy phaco efficiently removes hard cataracts
December 15th 2003Tokyo-A new approach to phacoemulsification incorporating prechopping and the Legacy (Alcon) system with its NeoSonix handpiece (Alcon) equipped with a specially designed ultrasound tip (Akahoshi tip) and using the AdvanTec short burst mode allows removal of even hard cataracts with a minimum of ultrasound energy, said Takayuki Akahoshi, MD.
Temporal hinge technique can yield many benefits in appropriate eyes
December 15th 2003Santa Monica, CA-A temporal hinge LASIK flap technique significantly increases the area of treatable corneal stromal bed for a given flap diameter compared with a superior hinge flap and offers a number of other advantages, including enabling retention of a broad hinge, said Kerry K. Assil, MD.
Ophthalmic market poised for upswing
December 15th 2003Marblehead, MA-As the year draws to a close, U.S. ophthalmologists are taking an assessment of where things stand in their practices and in the world around them. Many are finding comfort in the knowledge that the ophthalmic market continues to hold its own in an uncertain economic climate, said Kenneth P. Taylor in an independent analysis of the vision-care sector.
OCT more sensitive than visual field testing
December 1st 2003Boston-A recent study found that optical coherence tomography (OCT) seems to be more sensitive to changes in the retinal nerve fiber layer over time compared with standard visual field testing in patients with glaucoma, according to Gadi Wollstein, MD.
YAG laser iridotomy protects against pigmentary glaucoma
December 1st 2003Parma, Italy-YAG laser iridotomy has a protective effect in patients with pigment dispersion syndrome (PDS) who are at high risk of developing pigmentary glaucoma, according to the results of a 10-year follow-up study from the Institute of Ophthalmology in Parma, Italy.
FDA trial for toric ICL addresses myopic astigmatism
December 1st 2003Cincinnati, OH-Early results from an FDA clinical trial suggest that the toric implantable contact lens (ICL, STAAR Surgical) is extremely promising as a safe and effective alternative to LASIK for the correction of myopia with astigmatism, reported David Schneider, MD.